Search Login Register

Status Asthmaticus Summary

Description: A sudden intense and continuous aggravation of a state of asthma, marked by dyspnea to the point of exhaustion and collapse and not responding to the usual therapeutic efforts.

Also Known As: Asthmatic Crises; Asthmatic Shocks; Asthmaticus, Status; Crises, Asthmatic; Crisis, Asthmatic Show All >>

Networked: 560 relevant articles (42 outcomes, 43 trials/studies) for this Disease

Key Drugs and Agents for Status Asthmaticus

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Albuterol (Salbutamol) : 7 outcomes 5 studies in 34 results : FDA 92 Generic
  2. Terbutaline (Brethaire) : 4 outcomes 4 studies in 12 results : FDA 13 Generic
  3. Theophylline (Theon) : 4 outcomes 2 studies in 27 results : FDA 119 Generic
  4. Oxygen : 4 outcomes 2 studies in 20 results : IBA
  5. Adrenal Cortex Hormones (Corticosteroids) : 4 outcomes in 27 results : IBA
  6. Isoflurane : 3 outcomes 1 study in 21 results : FDA 7 Generic
  7. Isoproterenol (Isoprenaline) : 3 outcomes in 23 results : FDA 22 Generic
  8. heliox : 2 outcomes 1 study in 8 results : IBA
  9. Halothane (Fluothane) : 2 outcomes in 21 results : FDA 4
  10. Epinephrine (Adrenaline) : 2 outcomes in 12 results : FDA 93 Generic
Show All >>

Diseases Related to Status Asthmaticus

  1. Asthma (Bronchial Asthma)
  2. Respiratory Insufficiency (Respiratory Failure)
  3. Dyspnea (Shortness of Breath)
  4. Hypercapnia
  5. Bronchial Spasm
Show All >>

Key Therapies for Status Asthmaticus

Efficacy Chart >>
  1. Anesthesia : 4 outcomes 1 study in 20 results
  2. Artificial Respiration (Mechanical Ventilation) : 3 outcomes 7 studies in 85 results
  3. Nebulizers and Vaporizers (Inhaler) : 2 outcomes 1 study in 3 results
  4. Respiratory Therapy (Therapy, Respiratory) : 2 outcomes in 6 results
  5. Positive-Pressure Respiration (PEEP) : 1 outcome 1 study in 12 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.